Novozymes and Chr. Hansen agree deal to merge

Danish biotechnology companies Novozymes AS NZYM.B, -13.67% and Chr. Hansen Holding AS CHR, +23.64% said Monday they have agreed to merge, creating a biological solutions provider with combined annual...